Performance & Longevity

October 22, 2026

Personalized hormone testing for women: Why normal results don't always tell the whole story

Personalized hormone testing for women: Why normal results don't always tell the whole story

Hormone levels fluctuate throughout a woman's life, particularly during perimenopause and menopause. Here’s why “normal” lab results don’t always capture everything, when hormone testing can be useful, and how a personalized approach to care can help protect your long-term health.

Hormone levels fluctuate throughout a woman's life, particularly during perimenopause and menopause. Here’s why “normal” lab results don’t always capture everything, when hormone testing can be useful, and how a personalized approach to care can help protect your long-term health.

Women reviewing personal health information, highlighting personalized hormone testing and preventive care during perimenopause and menopause.

Published

October 22, 2026

Summarize this article

If you’re in your 40s or 50s and suddenly struggling with poor sleep, fatigue, brain fog, or changes in your body composition, you might wonder whether your hormones are partially to blame.

Hormones naturally shift across a woman’s menstrual cycle, and they change much more during perimenopause, the transition leading up to menopause. Periomenopause often lasts about four to eight years, though it varies widely from woman to woman. For women who have cycles, menopause is confirmed once you’ve gone 12 consecutive months without a period. [1]

During perimenopause, estrogen and progesterone can change considerably from one day to the next. That means a single blood test captures only one moment. It can’t show the full pattern of your transition, and it may not explain how you feel. A ‘normal’ result doesn’t mean your symptoms aren’t real.

That's why hormone evaluation should be personalized. The right tests, ordered at the right time, can add useful information. But results only become meaningful when they’re interpreted alongside your symptoms, menstrual history, age, and overall health. 

At Biograph, our goal isn’t to chase one ideal hormone range for every woman. It’s to understand how your unique hormonal changes may be affecting your health today and what they could mean for your long-term health, including your bone, heart, and metabolic health.

Why normal hormone levels don’t always mean everything is fine

When your lab results show that your estrogen falls within the normal range, that doesn’t necessarily tell you the whole story. It simply means your levels fall within a reference interval established for that test. Most reference intervals represent the middle 95% of results from a selected population, though methods vary by laboratory and hormone. [2]

Reference intervals are good at flagging clear abnormalities. But they often don’t account for where you are in your menstrual cycle, and they can’t capture how much hormones shift during midlife.

Estradiol, the main form  of estrogen, rises and falls across each cycle. Progesterone increases after ovulation and drops before your period. In perimenopause, both can swing widely from one day to the next. Estradiol can even run higher than usual at times. Progesterone tends to fall as ovulation becomes less regular. So the same result can look ‘normal’ one week and different the next. 

Hormone levels also don’t consistently match symptoms. If you’re having hot flashes that wake you up at night or noticeable mood changes, a normal estradiol or progesterone result doesn’t rule out perimenopause, and it doesn’t mean your symptoms aren’t real.. Not every symptom comes from a hormone deficiency either, and there isn't a scientifically established set of “optimal hormone levels” that guarantees better health or longevity.

Comprehensive hormone testing is valuable when you know which measurements are useful, when to order them, and how to interpret them in the context of your symptoms, history, and health goals.

When is a personalized hormone panel useful?

Hormone testing for women isn’t one-size-fits-all. For many otherwise healthy women over 45, perimenopause and menopause can be recognized from symptoms, changes in your cycle, and your medical history alone. Targeted testing becomes more useful  when symptoms are unusual, when menopause appears to be occurring early, when another condition could be responsible, or when your periods can’t be used as a guide (for example, after a hysterectomy or while using some types of hormonal birth control. [3]

Depending on the question you and your clinician are trying to answer, a comprehensive hormone panel may include:

  • Estradiol: The main form of estrogen made by the ovaries. It rises and falls across a normal cycle and can swing widely during perimenopause. After menopause, it settles at consistently low levels. Because it changes so much, a single estradiol result can’t confirm or rule out perimenopause.

  • Progesterone: Made mainly after ovulation. A level drawn about seven days before your expected period can show whether you ovulated that cycle. In perimenopause, ovulation happens less often, so progesterone often starts to fall earlier than estrogen.

  • FSH and luteinizing hormone (LH): Hormones released by the pituitary gland in the brain that signal the ovaries to mature and release an egg. As ovarian function winds down, FSH rises. A high FSH, especially with irregular or skipped periods, can support a diagnosis of perimenopause. FSH can also swing from month to month during this transition, so one normal value doesn’t rule it out. After menopause, FSH and LH stay elevated.

  • Testosterone and sex hormone-binding globulin (SHBG): Hormones measured to help evaluate certain androgen-related concerns, such as unwanted facial or body hair, persistent acne, or scalp hair thinning, which can be signs of conditions like polyendocrine metabolic ovarian syndrome (PMOS, formerly called polycystic ovary syndrome or PCOS).

  • Thyroid hormones: Thyroid stimulating hormone (TSH) with free T4  can identify an underactive or overactive thyroid Thyroid problems can cause fatigue, weight changes, menstrual changes, and mood symptoms that overlap with perimenopause.

  • Anti-mullerian hormone (AMH): Made by follicles in the ovaries, AMH estimates how many eggs remain (your “ovarian reserve”). Unlike estradiol and FSH, it stays fairly stable across the cycle. AMH declines through the late reproductive years and perimenopause and becomes essentially undetectable around menopause.

Timing also matters. For example, when evaluating ovulation, progesterone is generally measured about seven days before an expected period, rather than on an arbitrary cycle day.

Other tests may be appropriate depending on your symptoms, medications, reproductive history, and overall health. The goal isn’t to test every hormone – it’s to order the right tests at the right time to help guide your care.

A personalized approach to hormone health

Learn about our whole-person approach, integrating health history, hormone testing, and Biograph’s five key pillars to create a path forward.

Close-up of a blooming flower, symbolizing natural transitions, renewal, and personalized women's health care.

A personalized approach to hormone health

Learn about our whole-person approach, integrating health history, hormone testing, and Biograph’s five key pillars to create a path forward.

Close-up of a blooming flower, symbolizing natural transitions, renewal, and personalized women's health care.

A personalized approach to hormone health

Learn about our whole-person approach, integrating health history, hormone testing, and Biograph’s five key pillars to create a path forward.

Close-up of a blooming flower, symbolizing natural transitions, renewal, and personalized women's health care.

Why the bigger picture matters more than a single blood test

In women’s health, symptoms don’t always show up the way we expect. 

Hot flashes and irregular periods are the familiar signs of the menopause transition. But poor sleep, mood changes, and brain fog are common too, and they’re easy to put down to stress or aging. Other changes, such as bone loss and rising cholesterol, happen silently. You often can’t feel them until they’ve progressed. 

That’s why a lab value alone rarely tells the full story. This Biograph member’s experience illustrates why looking at the bigger picture matters.

How Biograph approaches it

This is the philosophy behind Biograph’s Women’s Health Program, and importantly, it does not stand alone. The program is embedded within the larger Biograph member journey, which is what makes it different. Rather than acting as a separate evaluation focused on reproductive organs or menopause symptoms, the program is a deep dive into a woman’s whole health, of which reproductive history and menopause evaluation is a necessary, but not sufficient, part.

The answer to a market that’s still underserving women isn’t a better-marketed one. It’s better medicine. The encouraging part of the story is that there is a real and growing community of clinicians and researchers committed to doing this the right way. At Biograph, we are committed to a genuine, clinical responsibility to care for women with both rigor and nuance, including being candid about where the gray areas still are in this dynamically changing landscape.

Biograph member Debbie M. shares her experience with menopause-related sleep difficulties and personalized physician-led care.

DEBBIE M.

When menopause affects sleep

At 56, Debbie was sleeping just two to three hours a night. She didn’t have the classic menopause symptoms she’d heard about, so she never connected her insomnia to hormonal changes.

During her Biograph assessment, her physician took a fuller look. That meant reviewing her symptoms and history, considering other causes of poor sleep, and recognizing that menopause was likely playing a role. After discussing the benefits and risks, Debbie started hormone therapy as part of her care plan, along with sleep-focused support. 

“Biograph changed my life in a way I didn’t expect. I went from barely sleeping to getting 7-9 hours a night. They helped me understand what was really going on and pointed me toward the right support. It felt personal, thoughtful, and truly life-changing,” she says.

However, not every case of insomnia is hormone-related. Sleep apnea, medications, mood changes, and other conditions can all disrupt sleep. That’s why we look for the underlying cause first. When hormone therapy is the right fit, our Biograph physicians can now prescribe and monitor it, so your care stays in one place.

Biograph member Debbie M. shares her experience with menopause-related sleep difficulties and personalized physician-led care.

DEBBIE M.

When menopause affects sleep

At 56, Debbie was sleeping just two to three hours a night. She didn’t have the classic menopause symptoms she’d heard about, so she never connected her insomnia to hormonal changes.

During her Biograph assessment, her physician took a fuller look. That meant reviewing her symptoms and history, considering other causes of poor sleep, and recognizing that menopause was likely playing a role. After discussing the benefits and risks, Debbie started hormone therapy as part of her care plan, along with sleep-focused support. 

“Biograph changed my life in a way I didn’t expect. I went from barely sleeping to getting 7-9 hours a night. They helped me understand what was really going on and pointed me toward the right support. It felt personal, thoughtful, and truly life-changing,” she says.

However, not every case of insomnia is hormone-related. Sleep apnea, medications, mood changes, and other conditions can all disrupt sleep. That’s why we look for the underlying cause first. When hormone therapy is the right fit, our Biograph physicians can now prescribe and monitor it, so your care stays in one place.

Biograph member Debbie M. shares her experience with menopause-related sleep difficulties and personalized physician-led care.

DEBBIE M.

When menopause affects sleep

At 56, Debbie was sleeping just two to three hours a night. She didn’t have the classic menopause symptoms she’d heard about, so she never connected her insomnia to hormonal changes.

During her Biograph assessment, her physician took a fuller look. That meant reviewing her symptoms and history, considering other causes of poor sleep, and recognizing that menopause was likely playing a role. After discussing the benefits and risks, Debbie started hormone therapy as part of her care plan, along with sleep-focused support. 

“Biograph changed my life in a way I didn’t expect. I went from barely sleeping to getting 7-9 hours a night. They helped me understand what was really going on and pointed me toward the right support. It felt personal, thoughtful, and truly life-changing,” she says.

However, not every case of insomnia is hormone-related. Sleep apnea, medications, mood changes, and other conditions can all disrupt sleep. That’s why we look for the underlying cause first. When hormone therapy is the right fit, our Biograph physicians can now prescribe and monitor it, so your care stays in one place.

Why the menopause transition matters for long-term health

Perimenopause and menopause are more than reproductive milestones. The hormonal shifts of this transition affect your heart, bones, metabolism, sleep, and brain, and some of those effects last for decades. The good news is that this window is also one of the best times to act. The changes are predictable, many are measurable before they cause problems, and much of the risk can be modified.

Cardiovascular and metabolic health

In the years around your final period, LDL cholesterol typically rises, fat shifts toward the abdomen (including the more harmful type of visceral fat around the organs), and blood vessels become stiffer. Research shows these changes go beyond what aging alone explains.

These changes can contribute to your cardiovascular risk, although hormones aren’t the whole story. Genetics, blood pressure, blood sugar, lifestyle all shape your risk. That’s why we look at your hormonal stage alongside lipid levels, cardiovascular imaging, body composition, and other established risk factors. The goal is to address early, while it’s most modifiable.

Bone and musculoskeletal health

Estrogen supports bone, muscle, cartilage, and connective tissue. As it declines, two very different things can happen: one you can feel, and one you usually can’t.

What you might feel: joint and muscle aches. New aches, stiffness, or muscle pain affect more than 70% of women during the transition. Joint pain also has other causes, such as osteoarthritis, injury, or inflammatory conditions, so new or persistent symptoms are worth getting checked.

What you can’t feel: bone loss. As estrogen falls, bone breaks down faster than it’s rebuilt, increasing the risk of osteoporosis later on. Osteoporosis usually causes no symptoms until a fracture happens. We assess bone density more proactively, rather than waiting for a break. [4]

Achy joints don’t mean you’re losing bone, and pain-free joints don’t mean your bones are strong. A thorough evaluation allows a deeper understanding of your musculoskeletal health, whether symptomatic or not.

Sleep, mood, and cognitive health

Sleep problems are common during perimenopause. Hot flashes and night sweats are a frequent cause, but poor sleep can also happen without them.

Many women also notice brain fog, forgetfulness, or trouble concentrating. Mood changes are common too. Some women notice irritability or low mood. Others experience anxiety for the first time, sometimes without any history of it. The risk of both depression and anxiety rises during perimenopause. 

While estrogen plays a role in brain function, these symptoms often have overlapping causes, including stress, thyroid problems, sleep disorders like sleep apnea, medication side effects, and other medical conditions. Identifying what’s actually driving your symptoms is what guides the right treatment, whether that’s hormone therapy, treatment for underlying sleep apnea, mental health support, lifestyle changes, something else, or a combination.

How Biograph approaches personalized hormone testing

Our Women’s Health Program brings together your health history, targeted hormone testing, preventive screening, and tailored care plans in one place. 

Before ordering any labs, we review your symptoms, menstrual and reproductive history, menopausal status, medications, medical and family history. Depending on your situation, we may measure estradiol, progesterone, FSH, LH, testosterone, SHBG, thyroid hormones, AMH, or other relevant biomarkers.

But hormone results are only one part of the picture. We also assess bone density and body composition with a DEXA scan, cardiovascular risk with bloodwork and imaging, and metabolic health with markers of insulin resistance. Many of these risks shift during the menopause transition, and most don’t cause symptoms.

Together, these findings help us identify potential health concerns and develop personalized recommendations that go beyond a single laboratory result.

What can you do about hormonal changes during midlife?

Not every hormonal change needs treatment. The right approach depends on your symptoms, your health history, and what matters most to you. For many women, that means a combination of lifestyle changes and, when appropriate, medication. 

Start with the foundations: regular resistance training and aerobic exercise support bone, muscle, and heart health. Good nutrition, quality sleep, and keeping blood pressure and cholesterol under control matter more than ever in midlife, because cardiovascular and bone risks rise during this transition. 

For women experiencing bothersome menopausal symptoms, menopausal hormone therapy (MHT) may be an option.

Systemic MHT is one of the most effective treatments for hot flashes and night sweats and can also help prevent bone loss. However, it isn’t FDA-approved to prevent cardiovascular disease or cognitive decline, though it may indirectly help reduce those factors. [5]

Your age, time since starting menopause, symptoms, whether you have a uterus, and medical history, including any history of blood clots, stroke, or certain cancers, all go into consideration when deciding if MHT is appropriate for you.

Hormone therapy also requires ongoing clinical follow-up. Treatment is adjusted based on symptom and side effects, rather than on repeated blood tests aiming for a target estradiol or progesterone level. [6]

The bottom line

A “normal” hormone result doesn’t always explain how you feel, especially during perimenopause, when levels can change from week to week. Testing more doesn’t always mean better care. Good care means choosing the right tests at the right time and reading the results alongside your symptoms, your reproductive stage, and your overall health.

Some of the most important changes in midlife, like bone loss and rising cardiovascular risk, cause no symptoms at all. That’s why looking only at hormones isn’t enough.

At Biograph, we bring all of this together in one place: a personalized evaluation, preventive screening, and physician-led care, including hormone therapy when it’s right for you. The goal is to help you feel better now and protect your health for decades to come.

Commonly asked questions about hormone testing for women

What does a comprehensive hormone panel test for in women?

Depending on the clinical question, testing may include estradiol, progesterone, FSH, LH, testosterone, SHBG, AMH, and thyroid hormones. Not every woman needs every test, and your lab results should always be interpreted alongside your symptoms and medical history.

Why can hormone tests be normal if I still have symptoms?

Hormone levels fluctuate throughout the menstrual cycle and perimenopause, so a single result may not reflect your overall hormonal pattern. Your symptoms may also be a product of causes that aren’t related to shifts in your reproductive hormones, which is why clinical evaluations are important.

What role does sex hormone-binding globulin (SHBG) play?

SHBG is a protein that binds sex hormones, including testosterone and estradiol, in the bloodstream. It influences how much hormone is available in its unbound form, so measuring SHBG can help interpret certain hormone results when relevant.

Does menopausal hormone therapy require ongoing biomarker monitoring?

MHT requires ongoing clinical follow-up, but routine hormone blood testing usually isn’t needed to adjust standard treatment. Physicians generally assess symptom relief, side effects, medical history, and changing risk factors, ordering additional tests when clinically indicated.

Woman emerging from the ocean, representing vitality, healthy aging, and a proactive approach to women's long-term health.

Understand your hormonal health

Discover how Biograph’s Women’s Health Program helps you navigate midlife changes and protect your long-term health.

Woman emerging from the ocean, representing vitality, healthy aging, and a proactive approach to women's long-term health.
Woman emerging from the ocean, representing vitality, healthy aging, and a proactive approach to women's long-term health.

Understand your hormonal health

Discover how Biograph’s Women’s Health Program helps you navigate midlife changes and protect your long-term health.

Woman emerging from the ocean, representing vitality, healthy aging, and a proactive approach to women's long-term health.
Woman emerging from the ocean, representing vitality, healthy aging, and a proactive approach to women's long-term health.

Understand your hormonal health

Discover how Biograph’s Women’s Health Program helps you navigate midlife changes and protect your long-term health.

Woman emerging from the ocean, representing vitality, healthy aging, and a proactive approach to women's long-term health.

Dr. Chen is a Clinic Physician at Biograph NYC. She joined Biograph after building her expertise at the intersection of innovation and academia. Her foundation includes a joint MD and MPH degree from Tulane University School of Medicine and completing both residency and Chief Residency in Internal Medicine at UCLA.

Clinical references

  1. Wegrzynowicz AK, Walls AC, Godfrey M, Beckley A. Insights into Perimenopause: A Survey of Perceptions, Opinions on Treatment, and Potential Approaches. Women. 2025;5(1):4-4. doi:10.3390/women5010004

  2. Daly CH, Higgins V, Adeli K, Grey VL, Hamid JS. Reference interval estimation: Methodological comparison using extensive simulations and empirical data. Clinical Biochemistry. 2017;50(18):1145-1158. doi:10.1016/j.clinbiochem.2017.07.005

  3. NICE. Recommendations | Menopause: diagnosis and management | Guidance | NICE. www.nice.org.uk. November 12, 2015. Accessed October 19, 2026. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations

  4. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. National Institute of Arthritis and Musculoskeletal and Skin Diseases. 2022. Accessed October 19, 2026. https://www.niams.nih.gov/health-topics/osteoporosis

  5. North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (New York, NY). 2022;29(7):767-794. doi:10.1097/GME.0000000000002028

  6. American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology. ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy. Obstetrics & Gynecology. 2023;142(5):1266-1273. doi:10.1097/aog.0000000000005395

  1. Wegrzynowicz AK, Walls AC, Godfrey M, Beckley A. Insights into Perimenopause: A Survey of Perceptions, Opinions on Treatment, and Potential Approaches. Women. 2025;5(1):4-4. doi:10.3390/women5010004

  2. Daly CH, Higgins V, Adeli K, Grey VL, Hamid JS. Reference interval estimation: Methodological comparison using extensive simulations and empirical data. Clinical Biochemistry. 2017;50(18):1145-1158. doi:10.1016/j.clinbiochem.2017.07.005

  3. NICE. Recommendations | Menopause: diagnosis and management | Guidance | NICE. www.nice.org.uk. November 12, 2015. Accessed October 19, 2026. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations

  4. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. National Institute of Arthritis and Musculoskeletal and Skin Diseases. 2022. Accessed October 19, 2026. https://www.niams.nih.gov/health-topics/osteoporosis

  5. North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (New York, NY). 2022;29(7):767-794. doi:10.1097/GME.0000000000002028

  6. American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology. ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy. Obstetrics & Gynecology. 2023;142(5):1266-1273. doi:10.1097/aog.0000000000005395

Latest from Biograph

Latest articles